[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341826-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-341826-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","quality-assurance-using-quality-indicators-for-prevention-and-early-detection-of-cervical-cancer-in-certified-gynaecological-dysplasia-units-and-consultancies","Quality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies","","Purpose Cervical cancer ranks fourth among women worldwide. An effective screening approach lowers both incidence and mortality. This paper evaluates quality indicators derived from cervical cancer screening guidelines and applied in certified gynaecological dysplasia units and consultancies, aiming to report current annual-report data. Methods Audit results and indicator outcomes for the 2022 audit year are presented, with analysed QI performance from certified centres. Results Nine QIs were assessed for indicator year 2021, with most targets met by consultancies and units. Conclusions Targets were largely achieved in the 2022 audit, supporting a continuous care pathway from prevention and early diagnosis through treatment via certified structures.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/quality-assurance-using-quality-indicators-for-prevention-and-early-detection-of-cervical-cancer-in-certified-gynaecological-dysplasia-units-and-consultancies/341826/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/quality-assurance-using-quality-indicators-for-prevention-and-early-detection-of-cervical-cancer-in-certified-gynaecological-dysplasia-units-and-consultancies/341826.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of evaluating quality indicators in this study?","Question",{"text":63,"@type":64},"To assess how quality indicators, derived from cervical cancer screening guidelines, are used within certified gynaecological dysplasia units and consultancies and to present their current annual-report data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data and audit period were analysed?",{"text":68,"@type":64},"Audit year 2022 results were analysed, including indicator year 2021 outcomes that were audited in 2022 and evaluated in 2023.",{"name":70,"@type":61,"acceptedAnswer":71},"How many quality indicators and certified centres were included?",{"text":72,"@type":64},"Nine quality indicators were analysed, based on 84 dysplasia consultancies and 42 units audited in 2022, with 40 units and 84 consultancies included in the annual report.",{"name":74,"@type":61,"acceptedAnswer":75},"What was the overall finding regarding target achievement?",{"text":76,"@type":64},"Most target goals were largely met, and where targets were not achieved auditors issued deviations or reduced certificate duration, alongside intensive case discussion and on-site measures determination.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},341826,1790276713,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":116,"preview_page_count":33,"preview_urls":149},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Archives of Gynecology and Obstetrics (2024) 310:2191–2202  \n[https://doi.org/10.1007/s00404-024-07694-w](https://doi.org/10.1007/s00404-024-07694-w)  \nQuality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies  \nLena Steinkasserer1 · Simone Wesselmann2 · Jens Quaas3 · Matthias W. Beckmann4 · Christian Dannecker5 · Jens Hachenberg1 · Matthias Jentschke1 · Peter Hillemanns1  \nReceived: 3 July 2024 / Accepted: 7 August 2024 / Published online: 29 August 2024 © The Author(s) 2024  \nAbstract  \nPurpose Cervical cancer is the fourth most common cancer in women worldwide. A successful screening concept for cervical cancer reduces the incidence and mortality of cervical cancer. Quality indicators (QIs) derived from the screening guidelines for cervical cancer and used by the certified dysplasia units and dysplasia consultancies are evaluated in this paper. The aim of this paper is to present the current data from the annual reports of these units and consultancies.  \nMethods The results of the basic data and indicators for the audit year 2022 in the gynaecological dysplasia consultancies and units are presented. In 2022, 84 dysplasia consultancies and 42 units were audited. 40 units and 84 consultancies are included in the annual report. QI outcomes for patients treated in certified dysplasia units and dysplasia consultancies are analysed. Median, overall proportion, and standard deviation were calculated for each QI.  \nResults The indicator year 2021 was analysed, which was audited in 2022 and evaluated in 2023. A total of nine QIs were analysed. Most target goals were met by the 84 certified dysplasia consultancies and by the 40 dysplasia units. The QIs evaluated are implemented to a very high degree. The targets for the three QIs were achieved by both the dysplasia consultancies and the units in at least 95% of the certified centres (QI 1: 100%, QI 2: 95%, QI 3: 100%; QI 1: 100%, QI 2: 97%, QI 3: 100%, respectively) . The presentation of patients to the tumour board by the consultancies/units is working; the units are attending the tumour board more regularly than in previous years. Where the target was not met, the auditors issued deviations or reduced the duration of the certificate. The cases are discussed intensively in the sense of an individual case analysis and with the determination of measures on-site.  \nConclusions The targets for the various indicators were largely met by the dysplasia consultancies and units in the 2022 audit year. The certification of gynaecological dysplasia consultancies/units which have to cooperate with certified gynaecological cancer centres, has for the first time ensured the continuity of healthcare from prevention and early diagnosis to treatment of gynaecological cancers.  \nKeywords Cervical cancer · Screening · Prevention · Quality indicators · Quality assurance · Dysplasia unit · Dysplasia consultancy  \nExtended author information available on the last page of the article  \nWhat does this study add to the clinical work  \nWith the certification of gynaecological dysplasia consultancies /units, the continuum of healthcare from prevention to treatment of gynaecological cancers in certified gynaecological cancer centres was ensured for the first time. The monitoring of defined quality indicators is intended to ensure that the quality of care in the dysplasia consultancies and units is guaranteed. QIs can be used to establish guideline-compliant treatment and motivate practitioners to review their treatment outcomes. The results of the QI reports are reported to the medical guideline development groups and provide information on whether and how the recommendations made are implemented in everyday clinical practice. They thus provide a stimulus for the further development of the corresponding guideline.  \nIntroduction  \nCervical cancer is the fourth most common cancer in women worldwide [1] . In 202","cbCaiuPbab1mtA75","https://ap.wps.com/l/cbCaiuPbab1mtA75","pdf",1031771,12,"English","# Abstract\n# Purpose\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Screening in Germany\n## Oncology Quality Cycle and Quality Indicators","[{\"question\":\"What is the purpose of evaluating quality indicators in this study?\",\"answer\":\"To assess how quality indicators, derived from cervical cancer screening guidelines, are used within certified gynaecological dysplasia units and consultancies and to present their current annual-report data.\"},{\"question\":\"Which data and audit period were analysed?\",\"answer\":\"Audit year 2022 results were analysed, including indicator year 2021 outcomes that were audited in 2022 and evaluated in 2023.\"},{\"question\":\"How many quality indicators and certified centres were included?\",\"answer\":\"Nine quality indicators were analysed, based on 84 dysplasia consultancies and 42 units audited in 2022, with 40 units and 84 consultancies included in the annual report.\"},{\"question\":\"What was the overall finding regarding target achievement?\",\"answer\":\"Most target goals were largely met, and where targets were not achieved auditors issued deviations or reduced certificate duration, alongside intensive case discussion and on-site measures determination.\"}]","Quality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies | PDF",1790044033,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e94338713dd53fda2334e9994cb26c25.webp",983,1305,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9b3a5119f4cc088305b6e6f7f2c71a6.webp",982,1304,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fc644f901e56a1445607e0c0e0d5715.webp",981,1303,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19f60e16c7a3bced2611a58e80f7eb7c.webp",980,1301]